JPH11171756A - Skin whitening cosmetic - Google Patents

Skin whitening cosmetic

Info

Publication number
JPH11171756A
JPH11171756A JP34999997A JP34999997A JPH11171756A JP H11171756 A JPH11171756 A JP H11171756A JP 34999997 A JP34999997 A JP 34999997A JP 34999997 A JP34999997 A JP 34999997A JP H11171756 A JPH11171756 A JP H11171756A
Authority
JP
Japan
Prior art keywords
skin
effect
hesperidin
whitening cosmetic
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP34999997A
Other languages
Japanese (ja)
Inventor
Kyotaro Hasunuma
喬太郎 蓮沼
Shusuke Hanaoka
秀典 花岡
Kazuyoshi Morita
和良 森田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP34999997A priority Critical patent/JPH11171756A/en
Publication of JPH11171756A publication Critical patent/JPH11171756A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject cosmetic having the effect of rapidly whitening the dark skin. SOLUTION: This skin whitening cosmetic is obtained by formulating a combination of a hesperidin compound with diisopropylamine dichloroacetate; wherein the amounts of the hesperidin compound and the diisopropylamine dichloroacetate to be formulated are appropriately 0.01-10 wt.% (esp. pref. 0.05-5 wt.%) based on the total amount of this cosmetic, respectively.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は色黒の皮膚を速やか
に淡色化する効果を有する美白化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a whitening cosmetic having an effect of rapidly lightening dark skin.

【0002】[0002]

【従来技術及び発明が解決しようとする課題】従来よ
り、肌のしみやそばかす等の予防や治療を目的とする美
白化粧料には、アスコルビン酸およびその誘導体、ハイ
ドロキノン誘導体、コウジ酸等のピロン類、プラセンタ
ーエキス等の胎盤抽出物が配合されている。
2. Description of the Related Art Conventionally, whitening cosmetics for the purpose of preventing and treating skin spots and freckles include ascorbic acid and its derivatives, hydroquinone derivatives, kojonic acid and other pyrones. And placenta extract such as placenta extract.

【0003】これらの物質は、メラニン生成の抑制、生
成したメラニンの淡色漂白作用等の効果を有し、美白効
果を有する物質として広く知られている。しかし、これ
らの物質は、例えばアスコルビン酸およびその誘導体
は、保存安定性が不十分であったり、紫外線による炎症
防止効果が十分に認められないことが多い。また、ハイ
ドロキノン誘導体は安全性が十分ではないなど問題があ
る。このようにメラニンの生成抑制効果、メラニンの淡
色漂白作用、炎症防止効果、安全性等において総合的に
優れる美白化粧料を得ることは困難である。
[0003] These substances have effects such as suppression of melanin production and pale bleaching action of the produced melanin, and are widely known as substances having a whitening effect. However, as for these substances, for example, ascorbic acid and its derivatives often have insufficient storage stability or an insufficient effect of preventing inflammation due to ultraviolet rays. Hydroquinone derivatives also have problems such as insufficient safety. As described above, it is difficult to obtain a whitening cosmetic which is totally excellent in melanin production inhibitory effect, melanin pale bleaching effect, anti-inflammatory effect, safety and the like.

【0004】即ち、本発明の目的は、メラニンの生成抑
制効果、メラニンの淡色漂白作用、に優れている美白化
粧料を提供することにある。
[0004] That is, an object of the present invention is to provide a whitening cosmetic which is excellent in the effect of inhibiting the production of melanin and the bleaching action of melanin in light color.

【0005】[0005]

【課題を解決するための手段】本発明者らは、上記目的
を達成するために鋭意検討した結果、ヘスペリジン化合
物とジイソプロピルアミンジクロロアセテートとを組み
合わせて配合した場合、メラニンの生成抑制効果、メラ
ニンの淡色漂白作用、に優れている美白化粧料が得られ
ることを見出し本発明を完成した。
Means for Solving the Problems The present inventors have conducted intensive studies to achieve the above object, and as a result, when a hesperidin compound and diisopropylamine dichloroacetate are combined, the effect of suppressing the production of melanin, The present inventors have found that a whitening cosmetic having excellent light-color bleaching action can be obtained and completed the present invention.

【0006】[0006]

【発明の実施の形態】以下、本発明の構成の詳細につい
て説明する。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The details of the structure of the present invention will be described below.

【0007】また、本発明に用いられるヘスペリジン化
合物とは、柑橘類の果皮などに含まれるヘスペリジン、
ネオヘスペリジンなどが挙げられ、例えばエタノール
水、エタノール、ジエチルエーテル、アセトン、ヘキサ
ンなどの有機溶媒系で抽出して得ることができ、更には
ヘスペリジンをジメチル硫酸でメチル化合成して得られ
るメチルヘスペリジンなども挙げることができる。
The hesperidin compound used in the present invention includes hesperidin contained in citrus peel and the like.
Neohesperidin and the like, for example, can be obtained by extraction with an organic solvent system such as ethanol water, ethanol, diethyl ether, acetone, hexane and the like, and further, methyl hesperidin obtained by methylation synthesis of hesperidin with dimethyl sulfate Can also be mentioned.

【0008】本発明に用いられるヘスペリジン化合物の
配合量としては、当該美白化粧料の総量を基準として、
0.01〜10重量%が相応しく、特に0.05〜5重
量%が好ましい。0.01重量%より少ないと効果の発
現性が充分でなく、また10重量%より多い量ではそれ
以上の効果はそれ程期待できない。
The compounding amount of the hesperidin compound used in the present invention is based on the total amount of the whitening cosmetic.
0.01 to 10% by weight is suitable, and particularly preferably 0.05 to 5% by weight. When the amount is less than 0.01% by weight, the manifestation of the effect is not sufficient, and when the amount is more than 10% by weight, no further effect can be expected.

【0009】また、本発明で用いるジイソプロピルアミ
ンジクロロアセテート(DADAと略称)とは、下記式
で示されるもので、白色結晶性の粉末状を呈し、匂いは
殆んどなく、味は苦く、水、エタノール等に溶けやす
い。また、その融点は、118〜122℃で5%水溶液
のpHは5.6〜6.8である。
Further, diisopropylamine dichloroacetate (abbreviated as DADA) used in the present invention is represented by the following formula, is in the form of a white crystalline powder, has almost no smell, has little bitter taste, Easy to dissolve in ethanol, etc. The melting point is 118-122 ° C, and the pH of a 5% aqueous solution is 5.6-6.8.

【0010】[0010]

【化1】 Embedded image

【0011】本発明に用いられるジイソプロピルアミン
ジクロロアセテートの配合量としては、当該美白化粧料
の総量を基準として、0.01〜10重量%が相応し
く、特に0.05〜5重量%が好ましい。0.01重量
%より少ないと効果の発現性が充分でなく、また10重
量%より多い量ではそれ以上の効果はそれ程期待できな
い。
The compounding amount of diisopropylamine dichloroacetate used in the present invention is suitably 0.01 to 10% by weight, particularly preferably 0.05 to 5% by weight, based on the total amount of the whitening cosmetic. When the amount is less than 0.01% by weight, the manifestation of the effect is not sufficient, and when the amount is more than 10% by weight, no further effect can be expected.

【0012】本発明の美白化粧料には、上記添加剤の他
に、色素、香料、防腐剤、界面活性剤、顔料、抗酸化
剤、保湿剤、紫外線吸収剤などを、本発明の目的を達成
する範囲内で適宜配合することができる。
The whitening cosmetic of the present invention contains, in addition to the above-mentioned additives, dyes, fragrances, preservatives, surfactants, pigments, antioxidants, humectants, ultraviolet absorbers and the like. It can be appropriately blended within the range achieved.

【0013】本発明の美白化粧料の剤型としては通常の
ものが適用され、たとえばクリーム、乳液、化粧水、パ
ック、エッセンス、粉体化粧料等が挙げられる。例えば
乳液の場合、油相及び水相をそれぞれ加熱溶解したもの
を乳化分散して冷却する通常の方法により製造すること
ができる。
[0013] As the dosage form of the whitening cosmetic of the present invention, conventional ones are applied, and examples thereof include creams, emulsions, lotions, packs, essences, and powdered cosmetics. For example, in the case of an emulsion, it can be produced by an ordinary method of emulsifying and dispersing an oil phase and an aqueous phase, each of which is heated and dissolved, and cooling.

【0014】[0014]

【実施例】以下、実施例及び比較例に基づいて本発明を
詳述する。尚、実施例に示す%とは重量%である。実施
例に記載の皮膚色明度回復試験法、官能評価試験は下記
のとおりである。
The present invention will be described below in detail based on examples and comparative examples. The percentages shown in the examples are percentages by weight. The skin color brightness recovery test method and the sensory evaluation test described in the examples are as follows.

【0015】(1)皮膚色明度回復試験法 被験者20名の背部皮膚にUV−B領域の紫外線を最小
紅斑量の2倍照射し、試料塗布部位と非塗布部位を設定
して各々の皮膚の基準明度(V0 値,V0 ´値)を測定
した。引き続いて塗布部位には試料を1日2回ずつ15
週間連続塗布した後、3,6,9,12,15週間後の
塗布部位及び非塗布部位の皮膚の明度(Vn 値,Vn ´
値)を測定し、下記の判定基準にしたがって皮膚色の回
復を評価した。尚、皮膚の明度(マンセル表色系V値)
は高速分光色彩計で測定して得られたX,Y,Z値より
算出した。また評価は被験者20名ついて、3週間後及
び6週間後の評価点の平均値で示した。
(1) Skin Lightness Recovery Test Method The back skin of 20 subjects was irradiated with ultraviolet rays in the UV-B region twice as much as the minimum erythema dose, and a sample-applied portion and a non-applied portion were set. The reference lightness (V0 value, V0 'value) was measured. Subsequently, the sample was applied to the application site twice a day for 15 times.
After continuous application for three weeks, the lightness (Vn value, Vn ') of the skin at the application site and the non-application site after 3, 6, 9, 12, and 15 weeks
Was measured, and the recovery of skin color was evaluated according to the following criteria. The lightness of the skin (Munsell color system V value)
Was calculated from the X, Y, and Z values obtained by measuring with a high-speed spectral colorimeter. In addition, the evaluation was shown as an average value of the evaluation points of the 20 subjects after 3 weeks and 6 weeks.

【0016】 [0016]

【0017】(2)官能評価試験 色素沈着に悩む被験者25名が試料を3週間連用し美白
効果を評価した。結果は「美白効果があった」と回答し
た被験者の人数で示した。
(2) Sensory Evaluation Test Twenty-five subjects suffering from pigmentation evaluated the whitening effect by using the sample continuously for three weeks. The results are shown by the number of subjects who answered that there was a whitening effect.

【0018】実施例1および2,比較例1〜3 (ヘスペリジンおよびメチルヘスペリジンの製法)ヘス
ペリジンは、ミカンの果皮を陰干し、乾燥させたものを
粉砕機で粉末にする。その粉末(50g)にエタノール
を400ml加え、75℃に加熱して、5時間還流し
た。該温浸によりエタノール抽出液を得た。エタノール
抽出液をエバポレーターにて溶媒除去し、ヘスペリジン
含有油状物質を得た。また、ヘスペリジン含有の前記エ
タノール抽出液にジメチル硫酸を常法により反応させ、
メチル化ヘスペリジンを得た。ヘスペリジン、メチルヘ
スペリジン、ジイソプロピルアミンジクロロアセテート
を表1の組成において配合し、下記の調製方法に基づい
てスキンクリームを調製した。
Examples 1 and 2, Comparative Examples 1 to 3 (Preparation of Hesperidin and Methyl Hesperidin) Hesperidin is obtained by shading the pericarp of mandarin orange and drying it into powder using a crusher. 400 ml of ethanol was added to the powder (50 g), heated to 75 ° C. and refluxed for 5 hours. An ethanol extract was obtained by the digestion. The solvent was removed from the ethanol extract using an evaporator to obtain an oil containing hesperidin. Further, dimethyl sulfate is reacted with the hesperidin-containing ethanol extract by a conventional method,
Methylated hesperidin was obtained. Hesperidin, methyl hesperidin, and diisopropylamine dichloroacetate were blended in the composition shown in Table 1, and a skin cream was prepared based on the following preparation method.

【0019】調製方法 (A)を70℃、Bを50℃にて均一に溶解し、(A)
を攪拌しながら(B)を(A)に注入して乳化分散した
後、攪拌しながら温度30℃まで冷却して調製する。
Preparation method (A) is uniformly dissolved at 70 ° C. and B is uniformly dissolved at 50 ° C.
After stirring (B) into (A) while stirring to emulsify and disperse, the mixture is cooled to 30 ° C. while stirring to prepare.

【0020】[0020]

【表1】 [Table 1]

【0021】[0021]

【表2】 [Table 2]

【0022】これらのスキンクリームを試料として前記
の試験を実施し、得られた結果を表3に示す。
The above test was carried out using these skin creams as samples, and the results obtained are shown in Table 3.

【0023】[0023]

【表3】 [Table 3]

【0024】これらの結果から分かるように、本発明の
実施例1および2のスキンクリームは、十分な美白効果
が認められた。また、実施例1および2のスキンクリー
ムは、肌がなめらかですべすべした状態になることを認
めた。一方、比較例1〜3のスキンクリームは、十分な
効果が認められず、本発明の実施例に比べて劣ってい
た。
As can be seen from these results, the skin creams of Examples 1 and 2 of the present invention exhibited a sufficient whitening effect. In addition, the skin creams of Examples 1 and 2 were found to have a smooth and smooth skin. On the other hand, the skin creams of Comparative Examples 1 to 3 did not show a sufficient effect, and were inferior to the examples of the present invention.

【0025】[0025]

【発明の効果】以上記載のごとく、本発明が色黒の皮膚
を速やかに淡色化する効果を有する美白化粧料を提供す
ることは明らかである。
As described above, it is apparent that the present invention provides a whitening cosmetic having an effect of rapidly lightening dark skin.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 ヘスペリジン化合物とジイソプロピルア
ミンジクロロアセテートとを組み合わせて配合すること
を特徴とする美白化粧料。
1. A whitening cosmetic comprising a combination of a hesperidin compound and diisopropylamine dichloroacetate.
JP34999997A 1997-12-03 1997-12-03 Skin whitening cosmetic Pending JPH11171756A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP34999997A JPH11171756A (en) 1997-12-03 1997-12-03 Skin whitening cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34999997A JPH11171756A (en) 1997-12-03 1997-12-03 Skin whitening cosmetic

Publications (1)

Publication Number Publication Date
JPH11171756A true JPH11171756A (en) 1999-06-29

Family

ID=18407554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP34999997A Pending JPH11171756A (en) 1997-12-03 1997-12-03 Skin whitening cosmetic

Country Status (1)

Country Link
JP (1) JPH11171756A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005132793A (en) * 2003-10-31 2005-05-26 Univ Kinki Bleaching agent or dyspigmentation-improving agent
WO2006103939A1 (en) * 2005-03-29 2006-10-05 A Pharma Kindai Co., Ltd. Whitening agent or pigmentation improving agent based on antioxidative action of neohesperidin
JP2009073769A (en) * 2007-09-21 2009-04-09 Nof Corp Melanin formation inhibitor and cosmetic for bleaching
JP2011527304A (en) * 2008-07-10 2011-10-27 ユニリーバー・ナームローゼ・ベンノートシヤープ Skin whitening method
WO2014181716A1 (en) * 2013-05-10 2014-11-13 昭和電工株式会社 Glycation inhibitor

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005132793A (en) * 2003-10-31 2005-05-26 Univ Kinki Bleaching agent or dyspigmentation-improving agent
WO2006103939A1 (en) * 2005-03-29 2006-10-05 A Pharma Kindai Co., Ltd. Whitening agent or pigmentation improving agent based on antioxidative action of neohesperidin
JP2006273736A (en) * 2005-03-29 2006-10-12 A Pharma Kindai Co Ltd Bleaching agent based on antioxidative action of neohesperidin or chromatosis improving agent
JP4654060B2 (en) * 2005-03-29 2011-03-16 株式会社 ア・ファーマ近大 Whitening agent or pigmentation ameliorating agent based on the antioxidant action of neohesperidin
JP2009073769A (en) * 2007-09-21 2009-04-09 Nof Corp Melanin formation inhibitor and cosmetic for bleaching
JP2011527304A (en) * 2008-07-10 2011-10-27 ユニリーバー・ナームローゼ・ベンノートシヤープ Skin whitening method
WO2014181716A1 (en) * 2013-05-10 2014-11-13 昭和電工株式会社 Glycation inhibitor
JPWO2014181716A1 (en) * 2013-05-10 2017-02-23 昭和電工株式会社 Saccharification reaction inhibitor

Similar Documents

Publication Publication Date Title
FR2577805A1 (en) SKIN TREATMENT COMPOSITION BASED ON HYDROQUINONE GLUCOSIDE
JP2890212B2 (en) Cosmetics
JP2002068940A (en) Composition for skin coloration including at least one kind of uv screening agent and flavylium salt having unsubstituted 3 position, and use of the same
JP3084104B2 (en) Cosmetics
JPH11171756A (en) Skin whitening cosmetic
JPH10279428A (en) Cosmetic
JPH08291039A (en) Skin-lightening cosmetic
JP2708692B2 (en) Whitening cosmetics
JP3452671B2 (en) External preparation for skin
JPH04346912A (en) Cosmetic
JP3229594B2 (en) Whitening cosmetics
JP2744485B2 (en) Whitening cosmetics
JP3045604B2 (en) Whitening cosmetics
JP2001131027A (en) Hair tonic and shampoo
JPH0363207A (en) Skin cosmetic
JP4063445B2 (en) Whitening cosmetics
JP2000290131A (en) Bleaching preparation
JP2000290134A (en) Bleaching preparation
JP2000297010A (en) Bleaching cosmetic
JP4063444B2 (en) Whitening cosmetics
JPH0859452A (en) Skin cosmetic
JP3649889B2 (en) Whitening cosmetics
JP2003206483A (en) Antioxidant and skin care preparation
JP3023249B2 (en) Whitening cosmetics
JP2671244B2 (en) Whitening cosmetics